Successful endoscopic stent placement as a bridge to surgery for XXXX induced by bevacizumab-based chemotherapy.

@entity1 @entity75 @entity1702 @entity14 @entity694
UNASSIGNED: The use of a @entity1702 ( @entity1702 ) as a bridge to surgery (BTS) for obstructive @entity14 is known to be effective. However, whether the use of a @entity1702 as a BTS for obstruction induced by effective chemotherapy (CTx) is useful is unknown. We present the case of a 54-year-old female @entity1 with @entity14 who underwent @entity1702 placement as a BTS for @entity14 induced by bevacizumab-based CTx. The @entity1 was diagnosed as having transverse @entity694 with multiple liver metastases invading the inferior vena cava. Bevacizumab-based CTx was started; however, although it was effective, @entity694 occurred at the primary site after 31  months. A @entity1702 was placed as a BTS, and surgical resection of the @entity75 was performed after cessation of bevacizumab. However, the liver metastases remained unresectable. CTx was restarted after surgery, and 48-month survival was achieved. This case shows that @entity1702 placement as a BTS for @entity14 induced by a good response to bevacizumab-based CTx was safe and beneficial. With the development of CTx and molecular-targeted agents, the frequency of @entity14 associated with effective CTx is expected to increase. @entity1702 placement as a BTS might be one of the treatment options.
